Macrilen

Active Ingredient(s): Macimorelin Acetate
FDA Approved: * December 20, 2017
Pharm Company: * AETERNA ZENTARIS
Category: Diagnostic Aid

Macimorelin (INN) – or Macrilen (trade name) – is a drug that was developed by Æterna Zentaris for use in the diagnosis of adult growth hormone deficiency.[2] Macimorelin acetate, the salt formulation, is a synthetic growth hormone secretagogue receptor agonist.[3] It is a growth hormone secretagogue receptor (ghrelin receptor) agonist causing release of growth hormone from the pituitary gland.[4][5][6&am... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Macrilen 60 mg/mg Oral Granule, for Solution

NDC: 0169-1401

Labeler:

Novo Nordisk

Macrilen 60 mg/mg Oral Granule, for Solution

NDC: 71090-002

Labeler:

Strongbridge U.S. Inc